Otros idiomas SofWave Medical Ltd.

Acciones

SOFW

IL0011754392

Diferido TEL AVIV STOCK EXCHANGE Otros sitios de cotización 10:31:58 03/07/2024			Varia. Cinco días.	Varia. 1 de enero.
1.740 ^ILa	+0,06 %		-1,81 %	+26,82 %

11/06	Sofwave Medical Ltd recibe la autorización de comercialización en Canadá para Pure Impact? dispositivo de fuerza y tonificación muscular	CI
09/05	SofWave Medical Ltd. Resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Sofwave Medical Receives Marketing Clearance in Canada for Pure Impact™ Strength and Muscle Toning Device	11/06
Sofwave Medical Ltd Receives Marketing Clearance in Canada for Pure Impact? Strength and Muscle Toning Device	11/06
Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights	09/05
SofWave Medical : Presentation- Q1 2024 Summary-May 2024	09/05
SofWave Medical Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Sofwave Medical to Participate in the Needham 23rd Annual Healthcare Conference	28/03
Sofwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	06/03
SofWave Medical : Presentation- Investor Meeting-March 2024	06/03
SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Sofwave Medical to Present Pure Impact™ Strength and Muscle Toning Module’s First U.S. Industry Reveal at the 2024 American Academy of Dermatology (AAD) Annual Meeting	04/03
Sofwave Medical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	28/02
Sofwave Medical Appoints Medical Aesthetics Industry Expert James Bartholomeusz to the Role of Chief Innovation Officer	12/02
SofWave Medical Ltd. Appoints James Bartholomeusz as Chief Innovation Officer	12/02
Sofwave Medical Receives 510(k) Marketing Clearance for Pure Impact™ Strength and Muscle Toning Body Module Utilizing PlyoPulse™ EMS Technology	03/01
Sofwave Medical Receives 510(K) Marketing Clearance for Pure Impact Strength and Muscle Toning Body Module Utilizing Plyopulse EMS Technology	03/01
Sofwave Medical Receives FDA Clearance of SUPERB™ Technology For Improvement of the Appearance of Skin Laxity on the Upper Arm	26/12
SofWave Medical Ltd. Receives FDA Clearance of Superb?? Technology for Improvement of the Appearance of Skin Laxity on the Upper Arm	26/12
Sofwave Earns Frost & Sullivan's 2023 North American Technology Innovation Leadership Award for Developing a Sophisticated Skin Tightening Ultrasound Technology with Minimal Downtime	20/11
Sofwave Medical Reports Third Quarter 2023 Financial Results and Business Highlights	08/11
SofWave Medical Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas SofWave Medical Ltd.

Acciones

SOFW

IL0011754392

Otros idiomas

Filtros